Overview

Reducing Mortality in Adults With Advanced HIV Disease (REVIVE)

Status:
Not yet recruiting
Trial end date:
2026-12-31
Target enrollment:
Participant gender:
Summary
A double blinded, placebo-controlled, multicenter trial to evaluate effectiveness of azithromycin prophylaxis on mortality in advanced HIV.
Phase:
Phase 3
Details
Lead Sponsor:
Population Health Research Institute
Treatments:
Azithromycin